CanFite Biopharma Q4 2023 Earnings Significant EPS Surprise as Biotech Focuses on Clinical Pipeline Nicolet Bankshares Inc Q1 2026 Earnings Significant EPS Miss Amid Challenging Banking Environment ITRI Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Margin Expansion DORM Q1 2026 Earnings EPS Misses Estimates as Earnings Surprise Turns Negative ZYME Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss PALI Q1 2026 Earnings EPS Misses Estimates as Palisade Bio Advances Pipeline Efforts OGE Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds ITT Q1 2026 Earnings EPS Surpasses Estimates Despite Flat Revenue Visibility SUPV Q1 2026 Earnings Massive EPS Beat Drives 732 Stock Surge ANGO Q1 2026 Earnings Strong Profitability Surprise Drives Modest Stock Gain WERN Q1 2026 Earnings Unexpected Profit Surprises to the Upside as Werner Beats Expectations CorVel Corp Q1 2026 Earnings EPS of 061 Amid Flat Revenue and Negative Stock Reaction QFIN Q4 2025 Earnings EPS Misses Estimates as Stock Declines